Fibrolamellar Hepatocellular Carcinoma

• CLINICAL_TRIALS trial_result · 2026-02-12
  Clinical Trial Update: Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA [Phase 1]

  Phase 1 clinical trial is recruiting for a DNAJB1-PRKACA fusion peptide vaccine intended for fibrolamellar hepatocellular carcinoma and othe…

• CLINICAL_TRIALS trial_result · 2025-04-18
  Clinical Trial Update: A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma [Phase 2]

  Phase 2 open-label study of ENMD-2076 in patients with advanced fibrolamellar hepatocellular carcinoma and advanced hepatocellular carcinoma…

• CLINICAL_TRIALS trial_result · 2022-12-29
  Clinical Trial Update: Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) [Phase 2]

  Phase 2 trial updates on Everolimus with or without estrogen deprivation therapy in unresectable fibrolamellar hepatocellular carcinoma; res…

• CLINICAL_TRIALS trial_result · 2014-03-13
  Clinical Trial Update: Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma [Phase 2]

  A Phase 2 study of sunitinib in patients with advanced or inoperable fibrolamellar hepatocellular carcinoma has been terminated.